Acipimox
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C10AD06
CAS registry number (Chemical Abstracts Service)
0051037-30-0
Chemical Formula
C6-H6-N2-O3
Molecular Weight
154
Therapeutic Category
Antilipemic agent: Nicotinic acid derivative
Chemical Name
5-Methylpyrazinecarboxylic acid 4-oxide (WHO)
Foreign Names
- Acipimoxum (Latin)
- Acipimox (German)
- Acipimox (French)
- Acipimox (Spanish)
Generic Names
- Acipimox (OS: DCF, BAN)
- K 9321 (IS)
Brand Names
- Nedios
Nycomed, Netherlands - Olbetam
Il Dong, South Korea; Pfizer, Austria; Pfizer, Belgium; Pfizer, Switzerland; Pfizer, Chile; Pfizer, China; Pfizer, Denmark; Pfizer, United Kingdom; Pfizer, Hungary; Pfizer, Israel; Pfizer, Netherlands; Pfizer, New Zealand; Pfizer, Singapore; Pfizer, Thailand; Pfizer, Taiwan; Pfizer, South Africa; Pfizer Italia, Italy - Yiping
Lunan Pharm, China
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
